市場調査レポート
商品コード
1452401

欧州の創傷洗浄剤市場:分析・予測 (2023-2030年)

Europe Wound Cleanser Market: Analysis and Forecast, 2023-2030

出版日: | 発行: BIS Research | ページ情報: 英文 | 納期: 1~5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=153.40円
欧州の創傷洗浄剤市場:分析・予測 (2023-2030年)
出版日: 2024年03月18日
発行: BIS Research
ページ情報: 英文
納期: 1~5営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

欧州の創傷洗浄剤の市場規模は、2023年の4億6,070万米ドルから、予測期間中は2.95%のCAGRで推移し、2030年には5億6,480万米ドルの規模に成長すると予測されています。 同市場の成長はさまざまな要因によって促進されています。

これには、創傷洗浄剤をより広範囲に使用する必要がある慢性疾患の発生率の上昇、外科手術や外傷事故の増加、創傷洗浄剤製品の採用の増加、創傷感染症の有病率の上昇、より専門的な創傷治療クリニックの設立などが含まれ、高度な創傷治療ソリューションの需要を促進しています。

主要市場統計
予測期間 2023-2030年
2023年評価 4億6,070万米ドル
2030年予測 5億6,480万米ドル
CAGR 2.95%

欧州の創傷洗浄剤の市場はいくつかの重要な要因によって持続的な成長を遂げています。同地域では創傷感染症が増加しており、創傷洗浄剤の需要が高まっています。また、外科手術や外傷の件数が増加していることも市場の成長を後押ししています。創傷感染症の有病率の増加と相まって、創傷洗浄剤製品の受け入れと利用が増加し、市場成長の原動力となっています。さらに、同地域全体に創傷ケア専門クリニックが設立されたことで、洗浄剤を含む高度な創傷ケアソリューションに対する需要が高まっています。ヘルスケアシステムが患者の転帰と感染予防を優先させる中、欧州の創傷洗浄剤市場は継続的な成長を遂げ、医療従事者と患者の進化するニーズに対応するための技術革新の機会をメーカーに提供しています。

当レポートでは、欧州の創傷洗浄剤の市場を調査し、市場概要、主要動向、法規制環境、影響因子および機会の分析、市場規模の推移・予測、各種区分・国別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

市場の分類

セグメンテーション1:製品別

  • 市販クレンザー
  • 生理食塩水

セグメンテーション2:国別

  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • ポルトガル
  • オランダ
  • アイルランド
  • ベルギー
  • スイス
  • ノルウェー
  • デンマーク
  • スウェーデン
  • フィンランド
  • チェコ共和国
  • ロシア連邦
  • ポーランド
  • オーストリア
  • ルーマニア
  • スロバキア
  • ギリシャ
  • トルコ
  • ウクライナ

目次

エグゼクティブサマリー

第1章 市場

  • 市場の見通し
    • 製品の定義
    • 包含基準
    • 除外基準
    • 概要

第2章 業界の展望

  • 主要な動向
  • 機会の評価
  • 価格分析
  • サプライチェーン分析

第3章 COVID-19の影響

  • 市場全体への影響
  • COVID-19以前
  • COVID-19の最中
  • COVID-19以降

第4章 事業力学

  • 影響分析
  • 事業促進要因
    • 慢性疾患の有病率の増加により、創傷洗浄剤の使用量が増加
    • 外科および外傷の症例数の増加
    • 傷洗浄剤製品の受け入れと利用の増加
    • 創傷感染症の有病率の上昇
    • 創傷ケア専門クリニックの増加により高度な創傷ケア製品の需要が創出
  • 事業上の制約
    • 医学教育と認識の欠如
    • 適切な償還制度の欠如
  • 事業機会
    • 新興国への拡大

第5章 地域

  • 欧州の創傷洗浄剤市場
    • 法的枠組みと規制要件
    • 主な調査結果と機会の評価
    • 市場力学
    • 市場規模と予測

第6章 市場-競合ベンチマーキング・企業プロファイル

  • 市場シェア分析
  • アクティブ企業のエコシステム
  • 企業プロファイル
    • ACTO GmbH
    • B. Braun S.E.
    • Bactiguard AB
    • Coloplast Group
    • Molnlycke Health Care AB
    • Schulke & Mayr GmbH
    • Smith & Nephew
図表

List of Figures

  • Figure 1: Wound Cleanser Applications
  • Figure 2: Number of Wound Care Centers in Different Economies
  • Figure 3: Europe Wound Cleanser Market, $Million, 2021-2030
  • Figure 4: Wound Cleanser Market, Market Dynamics
  • Figure 5: Key Trends in the Wound Cleanser Market
  • Figure 6: Europe Wound Cleanser Market Share (by Product), 2022 and 2030
  • Figure 7: Wound Cleanser Market (by Region), $Million, 2022
  • Figure 8: Wound Cleanser Market: Research Methodology
  • Figure 9: Primary Research Methodology
  • Figure 10: Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 11: Top-Down Approach (Segment-Wise Analysis)
  • Figure 12: Wound Cleanser Market, Key Trends
  • Figure 13: Wound Cleanser Market, Key Trends, Opportunity Assessment, 2023-2030
  • Figure 14: Factors Influencing Pricing of Advanced Wound Care Products
  • Figure 15: Wound Cleanser Market, Supply Chain Analysis
  • Figure 16: Wound Cleanser Market, Impact Analysis
  • Figure 17: Burden of the Diabetic Foot
  • Figure 18: Ideal Properties of a Wound Cleanser
  • Figure 19: Some of the Wound Cleansers, Globally
  • Figure 20: Factors Acting as a Restraining Factor for the Adoption of Wound Cleansers
  • Figure 21: Wound Cleanser Market Share (by Region), 2021-2030
  • Figure 22: Europe Wound Cleanser Market, $Million, 2021-2030
  • Figure 23: Europe Wound Cleanser Market (by Product), $Million, 2021-2030
  • Figure 24: Germany Wound Cleanser Market, $Million, 2021-2030
  • Figure 25: U.K. Wound Cleanser Market, $Million, 2021-2030
  • Figure 26: France Wound Cleanser Market, $Million, 2021-2030
  • Figure 27: Italy Wound Cleanser Market, $Million, 2021-2030
  • Figure 28: Spain Wound Cleanser Market, $Million, 2021-2030
  • Figure 29: Portugal Wound Cleanser Market, $Million, 2021-2030
  • Figure 30: Netherlands Wound Cleanser Market, $Million, 2021-2030
  • Figure 31: Ireland Wound Cleanser Market, $Million, 2021-2030
  • Figure 32: Belgium Wound Cleanser Market, $Million, 2021-2030
  • Figure 33: Switzerland Wound Cleanser Market, $Million, 2021-2030
  • Figure 34: Norway Wound Cleanser Market, $Million, 2021-2030
  • Figure 35: Denmark Wound Cleanser Market, $Million, 2021-2030
  • Figure 36: Sweden Wound Cleanser Market, $Million, 2021-2030
  • Figure 37: Finland Wound Cleanser Market, $Million, 2021-2030
  • Figure 38: Czech Republic Wound Cleanser Market, $Million, 2021-2030
  • Figure 39: Russian Federation Wound Cleanser Market, $Million, 2021-2030
  • Figure 40: Poland Wound Cleanser Market, $Million, 2021-2030
  • Figure 41: Austria Wound Cleanser Market, $Million, 2021-2030
  • Figure 42: Romania Wound Cleanser Market, $Million, 2021-2030
  • Figure 43: Slovakia Wound Cleanser Market, $Million, 2021-2030
  • Figure 44: Greece Wound Cleanser Market, $Million, 2021-2030
  • Figure 45: Turkey Wound Cleanser Market, $Million, 2021-2030
  • Figure 46: Ukraine Wound Cleanser Market, $Million, 2021-2030
  • Figure 47: Wound Cleanser Market, Company Revenue Share Analysis, $Billion, 2022
  • Figure 48: ACTO GmbH: Product Portfolio
  • Figure 49: B. Braun S.E.: Product Portfolio
  • Figure 50: B. Braun S.E.: Overall Financials, 2020-2022
  • Figure 51: Bactiguard AB: Product Portfolio
  • Figure 52: Bactiguard AB: Overall Financials, 2020-2022
  • Figure 53: Coloplast Group: Product Portfolio
  • Figure 54: Coloplast Group: Overall Financials, 2020-2022
  • Figure 55: Coloplast Group: Net Revenue (by Business Segment), $Million, 2020-2022
  • Figure 56: Coloplast Group: Net Revenue (by Region), $Million, 2020-2022
  • Figure 57: Coloplast Group: R&D Expenditure, $Million, 2020-2022
  • Figure 58: Molnlycke Health Care AB: Product Portfolio
  • Figure 59: Molnlycke Health Care AB: Overall Financials, 2020-2022
  • Figure 60: Molnlycke Health Care AB: Net Revenue (by Segment), $Million, 2020-2022
  • Figure 61: Molnlycke Health Care AB: Net Revenue (by Country), $Million, 2020-2022
  • Figure 62: Molnlycke Health Care AB: Net Revenue (by Channel), $Million, 2020-2022
  • Figure 63: Schulke & Mayr GmbH: Product Portfolio
  • Figure 64: Smith & Nephew: Product Portfolio
  • Figure 65: Smith & Nephew: Overall Financials, 2020-2022
  • Figure 66: Smith & Nephew: Net Revenue (by Business Segment), $Million, 2020-2022
  • Figure 67: Smith & Nephew: Net Revenue (by Advanced Wound Management), $Million, 2020-2022
  • Figure 68: Smith & Nephew: Net Revenue (by Region), $Million, 2020-2022

List of Tables

  • Table 1: Key Questions Answered in the Report
  • Table 2: Some of the Wound Cleansers, Pricing
  • Table 3: Europe Wound Cleanser Market, Regulations
  • Table 4: Europe Wound Cleanser Market, Impact Analysis
  • Table 5: Wound Cleanser Market, Ecosystem of Active Players
目次
Product Code: BHM1929SS

Introduction to Europe Wound Cleanser Market

The Europe wound cleanser market was valued at $460.7 million in 2023 and is expected to reach $564.8 million by 2030, growing at a CAGR of 2.95% between 2023 and 2030. The growth of the wound cleanser market is propelled by various factors. These include the higher occurrence of chronic illnesses necessitating more extensive use of wound cleansers, an uptick in surgical and trauma incidents, increased adoption of wound cleanser products, heightened prevalence of wound infections, and the establishment of more specialized wound care clinics, which drives demand for advanced wound care solutions.

KEY MARKET STATISTICS
Forecast Period2023 - 2030
2023 Evaluation$460.7 Million
2030 Forecast$564.8 Million
CAGR2.95%

Market Introduction

The Europe wound cleanser market is experiencing sustained growth, driven by several key factors. The rise in prevalence of wound infections in the region, leading to a higher demand for wound cleansers. Additionally, rising numbers of surgical procedures and trauma cases further fuel market growth. Increased acceptance and utilization of wound cleanser products, coupled with a growing prevalence of wound infections, drive market growth. Furthermore, the establishment of specialized wound care clinics across Europe creates a demand for advanced wound care solutions, including cleansers. As healthcare systems prioritize patient outcomes and infection prevention, the Europe wound cleanser market is poised for continued growth, offering opportunities for manufacturers to innovate and meet the evolving needs of healthcare providers and patients alike.

Market Segmentation:

Segmentation 1: by Product

  • Commercial Cleanser
  • Saline

Segmentation 2: by Country

  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Portugal
  • Netherlands
  • Ireland
  • Belgium
  • Switzerland
  • Norway
  • Denmark
  • Sweden
  • Finland
  • Czech Republic
  • Russian Federation
  • Poland
  • Austria
  • Romania
  • Slovakia
  • Greece
  • Turkey
  • Ukraine

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

Some of the prominent names established in this market are:

  • ACTO GmbH
  • B. Braun S.E.
  • Bactiguard AB
  • Coloplast Group
  • Molnlycke Health Care AB
  • Schulke & Mayr GmbH
  • Smith & Nephew

Table of Contents

Executive Summary

Scope of Study

Research Methodology

1 Markets

  • 1.1 Market Outlook
    • 1.1.1 Product Definition
    • 1.1.2 Inclusion Criteria
    • 1.1.3 Exclusion Criteria
    • 1.1.4 Overview

2 Industry Outlook

  • 2.1 Key Trends
  • 2.2 Opportunity Assessment
  • 2.3 Price Analysis
  • 2.4 Supply Chain Analysis

3 Impact of COVID-19

  • 3.1 Impact on Overall Market
  • 3.2 Pre-COVID-19
  • 3.3 During COVID-19
  • 3.4 Post COVID-19

4 Business Dynamics

  • 4.1 Impact Analysis
  • 4.2 Business Drivers
    • 4.2.1 Increase in Prevalence of Chronic Disease Leading to Increase Utilization of Wound Cleansers
    • 4.2.2 Rising Number of Surgical and Trauma Cases
    • 4.2.3 Rising Acceptance and Utilization of Wound Cleanser Products
    • 4.2.4 Rise in Prevalence of Wound Infection
    • 4.2.5 Growing Number of Specialty Wound Care Clinics Creating a Demand for Advanced Wound Care Products
  • 4.3 Business Restraints
    • 4.3.1 Lack of Medical Education and Awareness
    • 4.3.2 Lack of Adequate Reimbursement Policies
  • 4.4 Business Opportunities
    • 4.4.1 Expansion into Emerging Economies

5 Regions

  • 5.1 Europe Wound Cleanser Market
    • 5.1.1 Legal Framework and Regulatory Requirements
    • 5.1.2 Key Findings and Opportunity Assessment
    • 5.1.3 Market Dynamics
      • 5.1.3.1 Impact Analysis
    • 5.1.4 Market Sizing and Forecast
      • 5.1.4.1 Europe Wound Cleanser Market (by Product)
      • 5.1.4.2 Europe Wound Cleanser Market (by Country)
        • 5.1.4.2.1 Germany
          • 5.1.4.2.1.1 Market Dynamics
          • 5.1.4.2.1.2 Market Size and Forecast
        • 5.1.4.2.2 U.K.
          • 5.1.4.2.2.1 Market Dynamics
          • 5.1.4.2.2.2 Market Size and Forecast
        • 5.1.4.2.3 France
          • 5.1.4.2.3.1 Market Dynamics
          • 5.1.4.2.3.2 Market Size and Forecast
        • 5.1.4.2.4 Italy
          • 5.1.4.2.4.1 Market Dynamics
          • 5.1.4.2.4.2 Market Size and Forecast
        • 5.1.4.2.5 Spain
          • 5.1.4.2.5.1 Market Dynamics
          • 5.1.4.2.5.2 Market Size and Forecast
        • 5.1.4.2.6 Portugal
          • 5.1.4.2.6.1 Market Dynamics
        • 5.1.4.2.7 Market Size and Forecast
        • 5.1.4.2.8 Netherlands
          • 5.1.4.2.8.1 Market Dynamics
          • 5.1.4.2.8.2 Market Size and Forecast
        • 5.1.4.2.9 Ireland
          • 5.1.4.2.9.1 Market Dynamics
          • 5.1.4.2.9.2 Market Size and Forecast
        • 5.1.4.2.10 Belgium
          • 5.1.4.2.10.1 Market Dynamics
          • 5.1.4.2.10.2 Market Size and Forecast
        • 5.1.4.2.11 Switzerland
          • 5.1.4.2.11.1 Market Dynamics
          • 5.1.4.2.11.2 Market Size and Forecast
        • 5.1.4.2.12 Norway
          • 5.1.4.2.12.1 Market Dynamics
          • 5.1.4.2.12.2 Market Size and Forecast
        • 5.1.4.2.13 Denmark
          • 5.1.4.2.13.1 Market Dynamics
          • 5.1.4.2.13.2 Market Size and Forecast
        • 5.1.4.2.14 Sweden
          • 5.1.4.2.14.1 Market Dynamics
          • 5.1.4.2.14.2 Market Size and Forecast
        • 5.1.4.2.15 Finland
          • 5.1.4.2.15.1 Market Dynamics
          • 5.1.4.2.15.2 Market Size and Forecast
        • 5.1.4.2.16 Czech Republic
          • 5.1.4.2.16.1 Market Dynamics
          • 5.1.4.2.16.2 Market Size and Forecast
        • 5.1.4.2.17 Russian Federation
          • 5.1.4.2.17.1 Market Dynamics
          • 5.1.4.2.17.2 Market Size and Forecast
        • 5.1.4.2.18 Poland
          • 5.1.4.2.18.1 Market Dynamics
          • 5.1.4.2.18.2 Market Size and Forecast
        • 5.1.4.2.19 Austria
          • 5.1.4.2.19.1 Market Dynamics
          • 5.1.4.2.19.2 Market Size and Forecast
        • 5.1.4.2.20 Romania
          • 5.1.4.2.20.1 Market Dynamics
          • 5.1.4.2.20.2 Market Size and Forecast
        • 5.1.4.2.21 Slovakia
          • 5.1.4.2.21.1 Market Dynamics
          • 5.1.4.2.21.2 Market Size and Forecast
        • 5.1.4.2.22 Greece
          • 5.1.4.2.22.1 Market Dynamics
          • 5.1.4.2.22.2 Market Size and Forecast
        • 5.1.4.2.23 Turkey
          • 5.1.4.2.23.1 Market Dynamics
          • 5.1.4.2.23.2 Market Size and Forecast
        • 5.1.4.2.24 Ukraine
          • 5.1.4.2.24.1 Market Dynamics
          • 5.1.4.2.24.2 Market Size and Forecast

6 Markets - Competitive Benchmarking & Company Profiles

  • 6.1 Market Share Analysis
  • 6.2 Ecosystem of Active Players
  • 6.3 Company Profiles
    • 6.3.1 ACTO GmbH
      • 6.3.1.1 Company Overview
      • 6.3.1.2 Role of ACTO GmbH in the Wound Cleanser Market
      • 6.3.1.3 Target Customers
      • 6.3.1.4 Analyst Perspectives
    • 6.3.2 B. Braun S.E.
      • 6.3.2.1 Company Overview
      • 6.3.2.2 Role of B. Braun S.E. in the Wound Cleanser Market
      • 6.3.2.3 Financials
      • 6.3.2.4 Target Customers
      • 6.3.2.5 Analyst Perspectives
    • 6.3.3 Bactiguard AB
      • 6.3.3.1 Company Overview
      • 6.3.3.2 Role of Bactiguard AB in the Wound Cleanser Market
      • 6.3.3.3 Financials
      • 6.3.3.4 Analyst Perspectives
    • 6.3.4 Coloplast Group
      • 6.3.4.1 Company Overview
      • 6.3.4.2 Role of Coloplast Group in the Wound Cleanser Market
      • 6.3.4.3 Financials
      • 6.3.4.4 Analyst Perspectives
    • 6.3.5 Molnlycke Health Care AB
      • 6.3.5.1 Company Overview
      • 6.3.5.2 Role of Molnlycke Health Care AB in the Wound Cleanser Market
      • 6.3.5.3 Financials
      • 6.3.5.4 Target Customers
      • 6.3.5.5 Analyst Perspectives
    • 6.3.6 Schulke & Mayr GmbH
      • 6.3.6.1 Company Overview
      • 6.3.6.2 Role of Schulke & Mayr GmbH in the Wound Cleanser Market
      • 6.3.6.3 Target Customers
      • 6.3.6.4 Analyst Perspectives
    • 6.3.7 Smith & Nephew
      • 6.3.7.1 Company Overview
      • 6.3.7.2 Role of Smith & Nephew in the Wound Cleanser Market
      • 6.3.7.3 Financials
      • 6.3.7.4 Recent Developments
      • 6.3.7.5 Target Customers
      • 6.3.7.6 Analyst Perspectives